This topic contains a solution. Click here to go to the answer

Author Question: Benzodiazepine medication is not recommended as a long-term solution for the treatment of insomnia ... (Read 56 times)

segrsyd

  • Hero Member
  • *****
  • Posts: 530
Benzodiazepine medication is not recommended as a long-term solution for the treatment of insomnia because of
 
  a. the addictive properties of these medications.
 b. rebound insomnia that occurs after the medication is discontinued.
  c. excessive sleepiness that may persist during the day.
 d. all of these

Question 2

All of the following are examples of causes of circadian rhythm sleep disorder EXCEPT
 
  a. jet lag.
 b. shift work.
 c. delayed sleep phase.
  d. sleep rebound.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

CharlieArnold

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

d

Answer to Question 2

d




segrsyd

  • Member
  • Posts: 530
Reply 2 on: Jun 22, 2018
Gracias!


T4T

  • Member
  • Posts: 348
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library